Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2/PHASE3
92 participants
INTERVENTIONAL
2010-12-31
2012-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of the Efficacy of Aromatherapy on the Well-being of Healthcare Professionals
NCT05373849
Aromatherapy for Stress and Burnout Among Healthcare Providers
NCT05114655
Effects of Aromatherapy on Anxiety in Invasive Radiologic Procedure
NCT03090750
Aromatherapy and Happiness
NCT05864222
The Effect of Aromatherapy on COVID-19-induced Anxiety
NCT04495842
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
stress reducing aroma
aroma with reported stress reducing effects
aroma
Comparison of known stress reducing aroma to placebo aromas without stress-reducing effects
Placebo aroma 1
aroma
Comparison of known stress reducing aroma to placebo aromas without stress-reducing effects
Placebo aroma 2
aroma
Comparison of known stress reducing aroma to placebo aromas without stress-reducing effects
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
aroma
Comparison of known stress reducing aroma to placebo aromas without stress-reducing effects
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* reporting moderate level of stress
* able to perceive aromas
* able to understand and follow study instructions
Exclusion Criteria
* reporting smell sensitivities or allergies
* smoking presently or in the past less than one year prior to enrollment
50 Years
85 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Oregon Health and Science University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Barry S. Oken
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Barry S Oken, MD
Role: PRINCIPAL_INVESTIGATOR
Oregon Health and Science University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Oregon Health & Science University
Portland, Oregon, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Chamine I, Oken BS. Aroma Effects on Physiologic and Cognitive Function Following Acute Stress: A Mechanism Investigation. J Altern Complement Med. 2016 Sep;22(9):713-21. doi: 10.1089/acm.2015.0349. Epub 2016 Jun 29.
Chamine I, Oken BS. Expectancy of stress-reducing aromatherapy effect and performance on a stress-sensitive cognitive task. Evid Based Complement Alternat Med. 2015;2015:419812. doi: 10.1155/2015/419812. Epub 2015 Jan 31.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB#00006890
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.